As a leading producer of generic drugs in Central and Eastern Europe, Russia and Kazakhstan, we create many opportunities for our employees to realize their full professional potential.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

ASYMCHEM AND LANOVA MEDICINES ENTER INTO PARTNERSHIP AGREEMENT, EXPANDING BIOLOGICAL CAPABILITIES

Asymchem | September 17, 2021

news image

Asymchem today announced a strategic partnership agreement to provide LaNova Medicines with one-stop services such as small molecule drugs, ADC project CMCs, R&D, production and IND China-US declaration. The collaboration between Asymchem and LaNova will include small molecule drugs, monoclonal antibodies, double antibodies, ADC projects and potentially other R&D and production initiatives. This partnership will take full advantage of Asymchem's recently co...

Read More

Pharmacy Market

ATARA BIOTHERAPEUTICS AND PIERRE FABRE ENTER STRATEGIC COLLABORATION TO COMMERCIALIZE TABELECLEUCEL (TAB-CEL®)

Atara Biotherapeutics, Inc. | October 04, 2021

news image

Atara Biotherapeutics, Inc. (Nasdaq: ATRA) and Pierre Fabre today announced an exclusive commercialization agreement for tabelecleucel (tab-cel®) in Europe, Middle East, Africa, and other select emerging markets for Epstein-Barr virus (EBV)-positive cancers. Atara will retain full rights to tab-cel® in other major markets, including North America, Asia Pacific, and Latin America. Under the terms of the agreement, Atara will receive an upfront payment of USD 45 million, and...

Read More

Pharmacy Market

INTEGRICHAIN AND VERATO PARTNER ON SECURING PATIENT PRIVACY DATA

PRNewswire | June 23, 2023

news image

IntegriChain, delivering pharma's only comprehensive technology, data, consulting, and outsourcing platform for data-driven commercialization, and Verato, the identity experts for healthcare, today announced a technology partnership. IntegriChain will utilize Verato's healthcare master data management (hMDM) solution to create a new ICyte Secure PHI Vault for securing protected health information (PHI) and personal identifiable information (PII). The vault receives and stores ident...

Read More

Pharmacy Market

KEEP, THE MODERN MEDICINE CABINET, ANNOUNCES PARTNERSHIP WITH MCKESSON CANADA

KEEP Labs Inc. | January 28, 2022

news image

KEEP Labs, the Modern Medicine Cabinet and KARE by KEEP Adherence Platform developers, are pleased to announce a partnership with McKesson Canada to provide a novel solution for Canadians taking specialty medications. A majority of healthcare activities occur in the home, making it a critical place to monitor, engage and support patients. KEEP's state of the art technology and intuitive design allows McKesson Canada to provide an award-winning adherence platform that supports ...

Read More
news image

Business Insights

ASYMCHEM AND LANOVA MEDICINES ENTER INTO PARTNERSHIP AGREEMENT, EXPANDING BIOLOGICAL CAPABILITIES

Asymchem | September 17, 2021

Asymchem today announced a strategic partnership agreement to provide LaNova Medicines with one-stop services such as small molecule drugs, ADC project CMCs, R&D, production and IND China-US declaration. The collaboration between Asymchem and LaNova will include small molecule drugs, monoclonal antibodies, double antibodies, ADC projects and potentially other R&D and production initiatives. This partnership will take full advantage of Asymchem's recently co...

Read More
news image

Pharmacy Market

ATARA BIOTHERAPEUTICS AND PIERRE FABRE ENTER STRATEGIC COLLABORATION TO COMMERCIALIZE TABELECLEUCEL (TAB-CEL®)

Atara Biotherapeutics, Inc. | October 04, 2021

Atara Biotherapeutics, Inc. (Nasdaq: ATRA) and Pierre Fabre today announced an exclusive commercialization agreement for tabelecleucel (tab-cel®) in Europe, Middle East, Africa, and other select emerging markets for Epstein-Barr virus (EBV)-positive cancers. Atara will retain full rights to tab-cel® in other major markets, including North America, Asia Pacific, and Latin America. Under the terms of the agreement, Atara will receive an upfront payment of USD 45 million, and...

Read More
news image

Pharmacy Market

INTEGRICHAIN AND VERATO PARTNER ON SECURING PATIENT PRIVACY DATA

PRNewswire | June 23, 2023

IntegriChain, delivering pharma's only comprehensive technology, data, consulting, and outsourcing platform for data-driven commercialization, and Verato, the identity experts for healthcare, today announced a technology partnership. IntegriChain will utilize Verato's healthcare master data management (hMDM) solution to create a new ICyte Secure PHI Vault for securing protected health information (PHI) and personal identifiable information (PII). The vault receives and stores ident...

Read More
news image

Pharmacy Market

KEEP, THE MODERN MEDICINE CABINET, ANNOUNCES PARTNERSHIP WITH MCKESSON CANADA

KEEP Labs Inc. | January 28, 2022

KEEP Labs, the Modern Medicine Cabinet and KARE by KEEP Adherence Platform developers, are pleased to announce a partnership with McKesson Canada to provide a novel solution for Canadians taking specialty medications. A majority of healthcare activities occur in the home, making it a critical place to monitor, engage and support patients. KEEP's state of the art technology and intuitive design allows McKesson Canada to provide an award-winning adherence platform that supports ...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us